Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract-Reference-Cited by-同舟云学术

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

Published:2007-05 Issue:3 Volume:368 Page:652-665
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Wu Herren,Pfarr David S.,Johnson Syd,Brewah Yambasu A.,Woods Robert M.,Patel Nita K.,White Wendy I.,Young James F.,Kiener Peter A.

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference28 articles.

1. Respiratory syncytial virus;Collins,1996

2. Bronchiolitis-associated hospitalizations among US children, 1980–1996;Shay;JAMA,1999

3. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

4. Respiratory syncytial virus;Collins,2001

5. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function;Beeler;J. Virol.,1989

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

2. Discovery of a Peptoid-Based Nanoparticle Platform for Therapeutic mRNA Delivery via Diverse Library Clustering and Structural Parametrization;ACS Nano;2024-08-06

3. A neutralizing antibody prevents postfusion transition of measles virus fusion protein;Science;2024-06-28

4. Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling;mAbs;2024-06-10

5. Preclinical animal models to evaluate therapeutic antiviral antibodies;Antiviral Research;2024-05